drugset / Trial / NCT00641264

Quality of Life Validation in Laryngitis

NCT00641264

Phase 4 Completed 90 enrolled AstraZeneca
NaSingle-groupOpen-labelDiagnostic

Summary

The primary purpose of this study was to establish the psychometric properties of a new disease specific Quality of Life questionnaire, the LPR-HRQL. The specific properties of the questionnaire that were evaluated were: validity, reliability, and responsiveness to change (as a measure of treatment effect).

Timeline

Start
2001-05
Primary completion
2003-06
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Omeprazole Other / unclassified 20 mg